… begin its annual summer recess so members can head home to meet with constituents. (The House will break from July … including health care reform and research funding, and show you how to take action on them. It's full of tips for building …

… the use of stem cells for treating Parkinson’s, we wanted to provide an update on this closely watched area of … to explore and develop recipes for coaxing stem cells to become dopamine-producing neurons that could potentially be … may hold potential to benefit people with Parkinson’s. However, it’s important to keep in mind that in their …

… According to a report in today’s New York Times , the European Medicines Agency has recommended that gene therapy be approved for use in a rare … the gene that makes the protein neurturin into targeted areas of the brain.  Neurturin is a type of protein …

… Voyager Therapeutics today announced positive interim results from an ongoing Phase Ib, open-label trial testing a gene therapy that helps the brain make dopamine … (VY-AADC01) delivers the gene that makes AADC to a targeted brain area (the putamen) to enhance dopamine …

… Alpha-synuclein — the protein that clumps together and, scientists believe, causes Parkinson’s … tracer and agree to make it available to the research community to advance ongoing and new studies into stopping … more poised to enter human testing in the next few years. However, the lack of an objective biological measure (or …

… for Parkinson's Research (MJFF) offers strategic insight on how philanthropy, industry and government organizations can … was produced in collaboration with experts from these sectors and highlights the unique challenges and lack of commercial incentives for testing approved drugs in new …